Company
Capstan Therapeutics
| Industry | a San Diego, CA-based biotechnology company dedicated to advancing in vivo reprogramming of cells through RNA delivery using targeted lipid nanoparticles (tLNP) |
|---|
Funding raised
| Company | Round | Date |
|---|---|---|
| Capstan Therapeutics | Series B Financing | 2024-03-21 |